At ABO Eye Institute, research and innovation are pivotal in advancing the diagnosis, treatment, and prevention of eye diseases and vision problems. Our dedicated efforts lead to the development of new technologies, therapies, and approaches that enhance patient outcomes and quality of life. By investing in research and innovation, we continuously evolve, offering new hope and improved results for patients with various eye conditions. Our focus ensures that eye care remains at the forefront of medical science, delivering cutting-edge solutions to preserve and restore vision.
Key Areas of Research and Innovation:
- Genetic Research:
Identifying genetic factors associated with eye diseases such as glaucoma, macular degeneration, and inherited retinal disorders, leading to targeted gene therapies and personalised medicine. - Stem Cell Therapy:
Exploring the potential of stem cells to regenerate damaged retinal cells, corneal tissues, and other ocular structures, with the aim of treating conditions like age-related macular degeneration and retinal dystrophies. - Advanced Imaging Techniques:
Developing new imaging technologies, including Optical Coherence Tomography (OCT), adaptive optics, and confocal microscopy, to provide detailed views of ocular structures and improve early detection and monitoring of eye diseases. - Artificial Intelligence (AI) and Machine Learning:
Using AI algorithms to analyse large datasets for more accurate diagnoses of eye conditions. AI aids in screening for diseases such as diabetic retinopathy and glaucoma and predicting disease progression. - Drug Delivery Systems:
Innovating methods for more effective delivery of medications to the eye, including sustained-release implants, nanoparticles, and gene-editing technologies, aiming to enhance treatment efficacy and reduce side effects. - Bionic Eyes and Retinal Implants:
Developing electronic retinal implants and bionic eyes to restore vision in patients with severe vision loss. These devices convert light into electrical signals that the brain can interpret as visual information. - 3D Printing and Biofabrication:
Utilizing 3D printing to create custom prosthetics, surgical models, and bioprinted tissues for corneal transplants, improving precision and personalization in eye care. - Teleophthalmology:
Expanding access to eye care through telemedicine platforms for remote consultations, screenings, and follow-up care, reaching underserved populations and enhancing access to specialised care. - Corneal Cross-Linking:
Refining techniques for corneal cross-linking to strengthen corneal tissue and halt the progression of keratoconus and other corneal ectatic disorders. - Vision Restoration Techniques:
Investigating approaches to restore vision, including optogenetics, which uses light to control retinal cells, and regenerative medicine strategies to repair damaged ocular tissues. - Public Health Initiatives:
Conducting epidemiological studies to understand the prevalence and risk factors of eye diseases and developing effective prevention and intervention programs. - Clinical Trials:
Evaluating the safety and efficacy of new treatments, drugs, and medical devices through clinical trials, essential for bringing innovative therapies to market. - Collaborative Research Networks:
Establishing partnerships and collaborative networks with academic institutions, healthcare providers, industry, and patient advocacy groups to accelerate research and innovation in eye care. - Education and Training:
Developing educational programs and training for healthcare professionals to stay updated on the latest advancements in eye care and enhance their skills in diagnosing and treating ocular conditions.